Lilly's Prevail walks away from gene editing collab with Precision

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 17, 2024 at 11:22: AM
via Nine months after Eli Lilly’s Prevail Therapeutics reduced the biobucks value of a gene editing deal with Precision Biosciences, the Big Pharma subsidiary has walked away from the partnership entirely.

article source
 

<



Similar threads

cafead
Lilly&#039;s Prevail, Capsida partner to develop gene therapies for nervous system diseases
Replies
0
Views
195
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Eli Lilly&#039;s drug for eczema
Replies
0
Views
6
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
&#039;We&#039;re pretty prolific&#039;: Lilly Catalyze360 looks to connect with emerging biotechs across &#039;all areas&#039;
Replies
0
Views
25
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lilly&#039;s tau drug for Alzheimer&#039;s flunks phase 2 test
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA says all doses of Lilly&#039;s weight-loss and diabetes drug are now available
Replies
0
Views
55
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote